Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Clinical trial NCT06610734 · RECRUITING
Trial details
- NCT number
- NCT06610734
- Sponsor
- Sichuan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-23
- Primary completion
- 2026-12-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.